KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Retained Earnings (2017 - 2025)

Historic Retained Earnings for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$711.7 million.

  • Bionano Genomics' Retained Earnings fell 573.47% to -$711.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$711.7 million, marking a year-over-year decrease of 573.47%. This contributed to the annual value of -$693.2 million for FY2024, which is 1927.31% down from last year.
  • As of Q3 2025, Bionano Genomics' Retained Earnings stood at -$711.7 million, which was down 573.47% from -$703.2 million recorded in Q2 2025.
  • Bionano Genomics' 5-year Retained Earnings high stood at -$153.6 million for Q1 2021, and its period low was -$711.7 million during Q3 2025.
  • Moreover, its 5-year median value for Retained Earnings was -$424.8 million (2023), whereas its average is -$450.9 million.
  • As far as peak fluctuations go, Bionano Genomics' Retained Earnings crashed by 7330.68% in 2023, and later crashed by 573.47% in 2025.
  • Over the past 5 years, Bionano Genomics' Retained Earnings (Quarter) stood at -$216.1 million in 2021, then tumbled by 61.35% to -$348.7 million in 2022, then plummeted by 66.67% to -$581.2 million in 2023, then dropped by 19.27% to -$693.2 million in 2024, then fell by 2.67% to -$711.7 million in 2025.
  • Its last three reported values are -$711.7 million in Q3 2025, -$703.2 million for Q2 2025, and -$696.3 million during Q1 2025.